Search
forProducts matching "phase iii clinical trial"
Tracking 1 products like 99 Pyrilutamide solution from by companies like MinoxidilMax. View product »
Sort by
Research
210-240 / 1000+ results![Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)](/images/research/53b858ed-6638-4c1c-b8da-05f9f90ebb11/small/23331.jpg)
research Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.
![Male hormonal contraception: looking back and moving forward](/images/research/0d0969d1-131a-4273-94a4-d20cabc8b1cf/small/20255.jpg)
research Male hormonal contraception: looking back and moving forward
New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.
![Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents](/images/research/619ed0e1-5502-4ab2-9b4e-b941eba51261/small/15227.jpg)
research Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.
![Anthracycline analogs The past, present, and future](/images/research/64655a85-e745-4907-af8d-4e695d19fcad/small/22726.jpg)
research Anthracycline analogs The past, present, and future
Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.
![Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)](/images/research/4c61c6b9-d0b0-4d42-9487-802c613af992/small/25814.jpg)
research Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.
![Therapeutic applications and pharmacoeconomics of microneedle technology](/images/research/f2d0bc0c-04d2-4e49-8ef2-df54027099dd/small/15993.jpg)
research Therapeutic applications and pharmacoeconomics of microneedle technology
Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.
![The role of androgens in hormone replacement therapy](/images/research/79170f72-592c-4562-b887-55331c0aa588/small/15254.jpg)
research The role of androgens in hormone replacement therapy
Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.
![The Enticing Path of miR Therapeutics: Difficult but Not without Prospects](/images/research/f9e0046e-d5fc-4835-885d-23b7453d984f/small/20721.jpg)
research The Enticing Path of miR Therapeutics: Difficult but Not without Prospects
Developing microRNA-based treatments is hard but has potential.
![Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies](/images/research/109b20c1-8c3e-4e99-806a-4ca306e9339b/small/4301.jpg)
research Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
Dutasteride is a safe and effective treatment for hair loss.
![Faculty Opinions recommendation of Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.](/images/research/7b161182-c610-4cce-ba09-d7f3d6dc5db9/small/25730.jpg)
research Faculty Opinions recommendation of Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.
New treatment with Wnt proteins and growth factors safely increases hair thickness.
![The <i><scp>BJUI</scp></i>'s clinical trials initiative](/images/research/aedad74c-ff19-4102-97e2-04d635a67989/small/33196.jpg)
research The BJUI 's clinical trials initiative
The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.
![Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer](/images/research/f1504af0-77f0-4c52-8599-10ea4707afcb/small/29881.jpg)
research Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.
![Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma](/images/research/9b436251-d26f-4875-ac8a-f2fddd0ffc67/small/29880.jpg)
research Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.
![Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study](/images/research/2b7ba820-37b2-4d35-97ae-86e90b030fae/small/22696.jpg)
research Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.
![Androgens and alopecia](/images/research/aa556b74-9231-4482-8dca-58281c43e902/small/20471.jpg)
research Androgens and alopecia
Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.
![Low‐level laser (light) therapy (LLLT) for treatment of hair loss](/images/research/e0fb14dd-69eb-41d8-9538-10dc14295d1a/small/16227.jpg)
research Low‐level laser (light) therapy (LLLT) for treatment of hair loss
Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.
![Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)](/images/research/269421c1-b740-46a5-8609-93ba99dbad7b/small/2473.jpg)
research Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.
![Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document](/images/research/e8f1a5d1-d6e7-46e9-9a7f-b768f1d6513e/small/18202.jpg)
research Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.
![Dermatological Drugs, Topical Agents, and Cosmetics](/images/research/3aa53468-f97d-4328-8986-e8b66c9c5aa3/small/16135.jpg)
research Dermatological Drugs, Topical Agents, and Cosmetics
The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.
![Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature](/images/research/6c06a63a-6167-4080-9af8-81c8036a4c78/small/18303.jpg)
research Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.
![Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)](/images/research/ea388217-7d5d-47ef-8fcd-e3341b934102/small/29888.jpg)
research Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.
![Prostate cancer update: 2007](/images/research/c85174b2-d40e-4a95-adaf-7f38215b51df/small/15042.jpg)
research Prostate cancer update: 2007
2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.
![Towards a consensus potency assay for mesenchymal stromal cells: a matrix analysis of cell source, donor variability and inflammatory stimuli to refine surrogate markers of immunomodulation](/images/research/30826832-129b-4acf-9b50-f87fc4325aad/small/21514.jpg)
research Towards a consensus potency assay for mesenchymal stromal cells: a matrix analysis of cell source, donor variability and inflammatory stimuli to refine surrogate markers of immunomodulation
ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.
![Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis](/images/research/281659ab-0f44-4d1c-a7e1-1756f33fde64/small/24780.jpg)
research Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.
![JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis](/images/research/ca9b23f7-49e8-45d8-94b3-89ea442ed497/small/31403.jpg)
research JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.
![Topical Janus kinase inhibitors: A review of applications in dermatology](/images/research/f7ff7d3a-9376-47a6-9e77-9641e12e8976/small/31520.jpg)
research Topical Janus kinase inhibitors: A review of applications in dermatology
Topical JAK inhibitors may help treat some skin conditions but need more research.
![Review of the 2024 American Academy of Dermatology (AAD) Annual Meeting](/images/research/1a887ed9-db76-4351-aeb8-f6c21c224049/small/36862.jpg)
research Review of the 2024 American Academy of Dermatology (AAD) Annual Meeting
New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.
![Aldesleukin](/images/research/7d8a649d-2fc5-414c-a1a1-2b314792e432/small/24288.jpg)
research Aldesleukin
Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.
![Baricitinib: A Review in Severe Alopecia Areata](/images/research/2fa19d6c-9047-408a-82d8-4ed09b428403/small/23324.jpg)
research Baricitinib: A Review in Severe Alopecia Areata
Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.